Next-generation sequencing (NGS) has transformed immune profiling, enabling deeper characterization of disease mechanisms, ...

The global clinical next-generation sequencing (NGS) market, valued at USD 6.2 billion in 2024, is expected to reach USD 15.2 billion by 2032 with a ...

By Hugo Francisco de Souza A landmark study harnesses long-read sequencing to reveal vast, previously undetected structural ...

Lt. Col. M. Kelly Hourihan, director of the division’s Special Pathogens Clinical Diagnostic Laboratory, said the project successfully demonstrated the value of next-generation sequencing ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalence and precision medicine advancements. Key trends ...

The U.S. Food and Drug Administration on Tuesday launched the beta version of precisionFDA, its new collaborative platform for the exploration of next-generation gene sequencing. First announced in ...

U.S. Sanger Sequencing Market to Hit USD 4.25 Billion by 2032 as Demand for Reliable Genetic Sequencing in Healthcare Intensifies.Austin, July 16, 2025 (GLOBE NEWSWIRE) -- Sanger Sequencing Market ...

Uncovering gene expression patterns, spatial transcriptomics bridges molecular analysis and tissue morphology, advancing research in various biological fields.

The Philippine Genome Center (PGC)-Visayas underscored the contribution of ‘next-generation sequencing’ in the field of ...